Eosinophils are important for your immune system’s response to infections and allergic reactions. In people with HES, chronically elevated eosinophil levels can infiltrate the body’s tissues, causing ...

The findings reveal that administering Depemokimab twice yearly significantly lowers the annualized rate of asthma ...

The FDA has approved Dupixent (dupilumab) as an add-on therapy for adults with poorly controlled COPD, especially those with ...

It’s part of the company’s focus on eosinophil-driven diseases, and ahead of that regulatory milestone I spoke with Tiffany Robinson-Smith, global medical affairs lead for biologics at GSK ...

TD Cowen analyst Joseph Thome maintained a Hold rating on Allakos (ALLK – Research Report) today. The company’s shares closed ...

These biologics lower eosinophil numbers in both blood and tissue, with the weight of evidence indicating that eosinophil depletion reduces asthma exacerbations 5, 6. “The approval of these ...

The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic ...

The hormone decreases a type of white blood cell that helps keep tumors in check; restricting the hormone could be a ...

LifeSci Capital analyst Sam Slutsky maintained a Hold rating on Allakos (ALLK – Research Report) today. The company’s shares closed ...

Estrogens are known to drive tumor growth in breast cancer cells that carry its receptors, but a new study unexpectedly finds that estrogens play a role in fueling the growth of breast cancers without ...

Dupilumab, an injectable interleukin (IL)-4 and IL-13 pathway inhibitor, recently received FDA approval as the first-ever ...